; (2) in clause (iii), by inserting and at the end; and (3) by adding at the end the following: (iv) access to illicit drugs (including fentanyl and other synthetic opioids) on school premises, and the effects of such substances on school safety and student health and well-being; . V School-based health centers and reporting 501. Naloxone in school-based health centers Section 399Z–1(f)(1)(A) of the Public Health Service Act ( 42 U.S.C. 280h–5(f)(1)(A) ) is amended— (1) in clause (iv), by striking and at the end and inserting or ; and (2) by adding at the end the following: (v) the purchase of naloxone to reverse the effects of opioid overdose, and the establishment of other programs to address and prevent the misuse of synthetic opioids, including fentanyl or any substituted derivative of fentanyl; and . 502. Amendments to the Monitoring the Future survey Beginning on January 1, 2026, the Director of the National Institute on Drug Abuse, in collaboration with the Secretary and the Director of the National Institutes of Health, shall require the survey funded by the National Institute on Drug Abuse and titled Monitoring the Future to include— (1) indicators to measure the use of, perception of harm of, and access to counterfeit or synthetic opioids among youth; and (2) where applicable, indicators to measure the extent to which respondents are aware of the counterfeit or synthetic nature of any opioids used or encountered by such respondents. 503. Youth Risk Behavior Survey The Director of the Centers for Disease Control and Prevention shall consult with experts regarding the potential inclusion in the data collection survey for the Youth Risk Behavior Surveillance System of— (1) questions related to the use of, awareness regarding, and exposure to counterfeit or synthetic opioids, including fentanyl